| . | Total . | Utah I . | Utah II . | Utah III . | Utah IV . |
|---|---|---|---|---|---|
| With LVH (in bold) . | (n = 122) . | (n = 5) . | (n = 70) . | (n = 32) . | (n = 15) . |
| Without LVH . | (n = 282) . | (n = 19) . | (n = 198) . | (n = 51) . | (n = 14) . |
| Age (years) | 65.4 ± 11.3 | 61.1.7 ± 12.2 | 65.0 ± 10.7 | 63.8 ± 13.5 | 72.1 ± 7.1 |
| 64.8 ± 12.3 | 63.9 ± 14.4 | 63.9 ± 12.3 | 67.4 ± 12.5 | 70 ± 7.8 | |
| Gender, n (%) | |||||
| Male | 95 (77.9) | 9 (100) | 55 (78.6) | 25 (78.1) | 10 (66.7) |
| 165 (58.5) | 13 (68.4) | 126 (63.6) | 22 (43.1) | 4 (28.6) | |
| Female | 27 (22.1) | 0 (0) | 15 (21.4) | 7 (21.9) | 5 (33.3) |
| 117 (41.5) | 6 (31.6) | 72 (36.4) | 29 (56.9) | 10 (71.4) | |
| HT | 89 (73) | 4 (80) | 49 (70) | 24 (75) | 12 (80) |
| 153 (54.3) | 11 (57.9) | 107 (54) | 26 (51) | 9 (64.3) | |
| DM | 35 (28.7) | 1 (20) | 19 (27.1) | 11 (34.4) | 4 (26.7) |
| 30 (10.6) | 2 (10.5) | 15 (7.6) | 11 (21.6) | 2 (14.3) | |
| CAD | 34 (27.9) | 2 (40) | 16 (22.9) | 11 (34.4) | 5 (33.3) |
| 39 (13.8) | 2 (10.5) | 27 (13.6) | 9 (17.6) | 1 (7.1) | |
| Smoker | 28 (23) | 2 (40) | 12 (17.1) | 9 (28.1) | 5 (33.3) |
| 62 (22) | 6 (31.6) | 46 (23.2) | 8 (15.7) | 2 (14.3) | |
| CHF | 15 (12.3) | 2 (40) | 9 (12.9) | 3 (9.4) | 1 (6.7) |
| 24 (8.5) | 1 (5.3) | 16 (8.1) | 5 (9.8) | 2 (14.3) | |
| CMP | 16 (13.1) | 1 (20) | 10 (14.3) | 2 (6.3) | 3 (20) |
| 25 (8.9) | 0 (0) | 15 (7.6) | 7 (13.7) | 3 (21.4) | |
| Stroke | 8 (6.6) | 0 (0) | 5 (7.1) | 2 (6.3) | 1 (6.7) |
| 28 (9.9) | 1 (5.3) | 16 (8.1) | 8 (15.7) | 3 (21.4) | |
| AF type | |||||
| Paroxysmal | 46 (37.7) | 4 (80) | 24 (34.3) | 15 (46.9) | 3 (20) |
| 152 (53.9) | 15 (78.9) | 113 (57.1) | 20 (39.2) | 4 (28.6) | |
| Persistent | 76 (62.3) | 1 (20) | 46 (65.7) | 17 (53.1) | 12 (80) |
| 130 (46.1) | 4 (21.1) | 85 (42.9) | 31 (60.8) | 10 (71.4) | |
| . | Total . | Utah I . | Utah II . | Utah III . | Utah IV . |
|---|---|---|---|---|---|
| With LVH (in bold) . | (n = 122) . | (n = 5) . | (n = 70) . | (n = 32) . | (n = 15) . |
| Without LVH . | (n = 282) . | (n = 19) . | (n = 198) . | (n = 51) . | (n = 14) . |
| Age (years) | 65.4 ± 11.3 | 61.1.7 ± 12.2 | 65.0 ± 10.7 | 63.8 ± 13.5 | 72.1 ± 7.1 |
| 64.8 ± 12.3 | 63.9 ± 14.4 | 63.9 ± 12.3 | 67.4 ± 12.5 | 70 ± 7.8 | |
| Gender, n (%) | |||||
| Male | 95 (77.9) | 9 (100) | 55 (78.6) | 25 (78.1) | 10 (66.7) |
| 165 (58.5) | 13 (68.4) | 126 (63.6) | 22 (43.1) | 4 (28.6) | |
| Female | 27 (22.1) | 0 (0) | 15 (21.4) | 7 (21.9) | 5 (33.3) |
| 117 (41.5) | 6 (31.6) | 72 (36.4) | 29 (56.9) | 10 (71.4) | |
| HT | 89 (73) | 4 (80) | 49 (70) | 24 (75) | 12 (80) |
| 153 (54.3) | 11 (57.9) | 107 (54) | 26 (51) | 9 (64.3) | |
| DM | 35 (28.7) | 1 (20) | 19 (27.1) | 11 (34.4) | 4 (26.7) |
| 30 (10.6) | 2 (10.5) | 15 (7.6) | 11 (21.6) | 2 (14.3) | |
| CAD | 34 (27.9) | 2 (40) | 16 (22.9) | 11 (34.4) | 5 (33.3) |
| 39 (13.8) | 2 (10.5) | 27 (13.6) | 9 (17.6) | 1 (7.1) | |
| Smoker | 28 (23) | 2 (40) | 12 (17.1) | 9 (28.1) | 5 (33.3) |
| 62 (22) | 6 (31.6) | 46 (23.2) | 8 (15.7) | 2 (14.3) | |
| CHF | 15 (12.3) | 2 (40) | 9 (12.9) | 3 (9.4) | 1 (6.7) |
| 24 (8.5) | 1 (5.3) | 16 (8.1) | 5 (9.8) | 2 (14.3) | |
| CMP | 16 (13.1) | 1 (20) | 10 (14.3) | 2 (6.3) | 3 (20) |
| 25 (8.9) | 0 (0) | 15 (7.6) | 7 (13.7) | 3 (21.4) | |
| Stroke | 8 (6.6) | 0 (0) | 5 (7.1) | 2 (6.3) | 1 (6.7) |
| 28 (9.9) | 1 (5.3) | 16 (8.1) | 8 (15.7) | 3 (21.4) | |
| AF type | |||||
| Paroxysmal | 46 (37.7) | 4 (80) | 24 (34.3) | 15 (46.9) | 3 (20) |
| 152 (53.9) | 15 (78.9) | 113 (57.1) | 20 (39.2) | 4 (28.6) | |
| Persistent | 76 (62.3) | 1 (20) | 46 (65.7) | 17 (53.1) | 12 (80) |
| 130 (46.1) | 4 (21.1) | 85 (42.9) | 31 (60.8) | 10 (71.4) | |
CAD, coronary artery disease; HT, hypertension; DM, diabetes mellitus; CHF, congestive heart failure; CMP, cardiomyopathy; AF, atrial fibrillation.
Continuous measurements are presented as mean ± SD. Categorical measurements are presented as number positive for the condition and percentage of the total.
| . | Total . | Utah I . | Utah II . | Utah III . | Utah IV . |
|---|---|---|---|---|---|
| With LVH (in bold) . | (n = 122) . | (n = 5) . | (n = 70) . | (n = 32) . | (n = 15) . |
| Without LVH . | (n = 282) . | (n = 19) . | (n = 198) . | (n = 51) . | (n = 14) . |
| Age (years) | 65.4 ± 11.3 | 61.1.7 ± 12.2 | 65.0 ± 10.7 | 63.8 ± 13.5 | 72.1 ± 7.1 |
| 64.8 ± 12.3 | 63.9 ± 14.4 | 63.9 ± 12.3 | 67.4 ± 12.5 | 70 ± 7.8 | |
| Gender, n (%) | |||||
| Male | 95 (77.9) | 9 (100) | 55 (78.6) | 25 (78.1) | 10 (66.7) |
| 165 (58.5) | 13 (68.4) | 126 (63.6) | 22 (43.1) | 4 (28.6) | |
| Female | 27 (22.1) | 0 (0) | 15 (21.4) | 7 (21.9) | 5 (33.3) |
| 117 (41.5) | 6 (31.6) | 72 (36.4) | 29 (56.9) | 10 (71.4) | |
| HT | 89 (73) | 4 (80) | 49 (70) | 24 (75) | 12 (80) |
| 153 (54.3) | 11 (57.9) | 107 (54) | 26 (51) | 9 (64.3) | |
| DM | 35 (28.7) | 1 (20) | 19 (27.1) | 11 (34.4) | 4 (26.7) |
| 30 (10.6) | 2 (10.5) | 15 (7.6) | 11 (21.6) | 2 (14.3) | |
| CAD | 34 (27.9) | 2 (40) | 16 (22.9) | 11 (34.4) | 5 (33.3) |
| 39 (13.8) | 2 (10.5) | 27 (13.6) | 9 (17.6) | 1 (7.1) | |
| Smoker | 28 (23) | 2 (40) | 12 (17.1) | 9 (28.1) | 5 (33.3) |
| 62 (22) | 6 (31.6) | 46 (23.2) | 8 (15.7) | 2 (14.3) | |
| CHF | 15 (12.3) | 2 (40) | 9 (12.9) | 3 (9.4) | 1 (6.7) |
| 24 (8.5) | 1 (5.3) | 16 (8.1) | 5 (9.8) | 2 (14.3) | |
| CMP | 16 (13.1) | 1 (20) | 10 (14.3) | 2 (6.3) | 3 (20) |
| 25 (8.9) | 0 (0) | 15 (7.6) | 7 (13.7) | 3 (21.4) | |
| Stroke | 8 (6.6) | 0 (0) | 5 (7.1) | 2 (6.3) | 1 (6.7) |
| 28 (9.9) | 1 (5.3) | 16 (8.1) | 8 (15.7) | 3 (21.4) | |
| AF type | |||||
| Paroxysmal | 46 (37.7) | 4 (80) | 24 (34.3) | 15 (46.9) | 3 (20) |
| 152 (53.9) | 15 (78.9) | 113 (57.1) | 20 (39.2) | 4 (28.6) | |
| Persistent | 76 (62.3) | 1 (20) | 46 (65.7) | 17 (53.1) | 12 (80) |
| 130 (46.1) | 4 (21.1) | 85 (42.9) | 31 (60.8) | 10 (71.4) | |
| . | Total . | Utah I . | Utah II . | Utah III . | Utah IV . |
|---|---|---|---|---|---|
| With LVH (in bold) . | (n = 122) . | (n = 5) . | (n = 70) . | (n = 32) . | (n = 15) . |
| Without LVH . | (n = 282) . | (n = 19) . | (n = 198) . | (n = 51) . | (n = 14) . |
| Age (years) | 65.4 ± 11.3 | 61.1.7 ± 12.2 | 65.0 ± 10.7 | 63.8 ± 13.5 | 72.1 ± 7.1 |
| 64.8 ± 12.3 | 63.9 ± 14.4 | 63.9 ± 12.3 | 67.4 ± 12.5 | 70 ± 7.8 | |
| Gender, n (%) | |||||
| Male | 95 (77.9) | 9 (100) | 55 (78.6) | 25 (78.1) | 10 (66.7) |
| 165 (58.5) | 13 (68.4) | 126 (63.6) | 22 (43.1) | 4 (28.6) | |
| Female | 27 (22.1) | 0 (0) | 15 (21.4) | 7 (21.9) | 5 (33.3) |
| 117 (41.5) | 6 (31.6) | 72 (36.4) | 29 (56.9) | 10 (71.4) | |
| HT | 89 (73) | 4 (80) | 49 (70) | 24 (75) | 12 (80) |
| 153 (54.3) | 11 (57.9) | 107 (54) | 26 (51) | 9 (64.3) | |
| DM | 35 (28.7) | 1 (20) | 19 (27.1) | 11 (34.4) | 4 (26.7) |
| 30 (10.6) | 2 (10.5) | 15 (7.6) | 11 (21.6) | 2 (14.3) | |
| CAD | 34 (27.9) | 2 (40) | 16 (22.9) | 11 (34.4) | 5 (33.3) |
| 39 (13.8) | 2 (10.5) | 27 (13.6) | 9 (17.6) | 1 (7.1) | |
| Smoker | 28 (23) | 2 (40) | 12 (17.1) | 9 (28.1) | 5 (33.3) |
| 62 (22) | 6 (31.6) | 46 (23.2) | 8 (15.7) | 2 (14.3) | |
| CHF | 15 (12.3) | 2 (40) | 9 (12.9) | 3 (9.4) | 1 (6.7) |
| 24 (8.5) | 1 (5.3) | 16 (8.1) | 5 (9.8) | 2 (14.3) | |
| CMP | 16 (13.1) | 1 (20) | 10 (14.3) | 2 (6.3) | 3 (20) |
| 25 (8.9) | 0 (0) | 15 (7.6) | 7 (13.7) | 3 (21.4) | |
| Stroke | 8 (6.6) | 0 (0) | 5 (7.1) | 2 (6.3) | 1 (6.7) |
| 28 (9.9) | 1 (5.3) | 16 (8.1) | 8 (15.7) | 3 (21.4) | |
| AF type | |||||
| Paroxysmal | 46 (37.7) | 4 (80) | 24 (34.3) | 15 (46.9) | 3 (20) |
| 152 (53.9) | 15 (78.9) | 113 (57.1) | 20 (39.2) | 4 (28.6) | |
| Persistent | 76 (62.3) | 1 (20) | 46 (65.7) | 17 (53.1) | 12 (80) |
| 130 (46.1) | 4 (21.1) | 85 (42.9) | 31 (60.8) | 10 (71.4) | |
CAD, coronary artery disease; HT, hypertension; DM, diabetes mellitus; CHF, congestive heart failure; CMP, cardiomyopathy; AF, atrial fibrillation.
Continuous measurements are presented as mean ± SD. Categorical measurements are presented as number positive for the condition and percentage of the total.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
